Keywords: CEL-SCI Corp, Miltikine, Argentina, Venezuela, IDC-GP Pharma, Head and neck cancer

CEL-SCI in deal to market Multikine in Argentina and Venezuela

Article | 24 August 2011

Print This

US drug developer CEL-SCI Corp (NYSE AMEX: CVM) has entered into an exclusive sales, marketing and distribution agreement with IDC-GP ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in